Navigation Links
OncoSec Medical to Present at the 25th Annual Roth Conference
Date:3/14/2013

erapies address an unmet medical need and represent a potential solution, for less invasive and less expensive therapies that are able to minimize detrimental effects resulting from currently available cancer treatments such as surgery, systemic chemotherapy or immunotherapy and other treatment alternatives.  OncoSec Medical's core technology is based upon its proprietary use of an electroporation platform to dramatically enhance the delivery and uptake of a locally delivered DNA-based immunocytokine (ImmunoPulse) or chemotherapeutic agent (NeoPulse). Treatment of various solid cancers using these powerful and targeted anti-cancer agents has demonstrated selective destruction of cancerous cells while sparing healthy normal tissues during early and late stage clinical trials. OncoSec's clinical programs include three Phase II clinical trials for ImmunoPulse targeting lethal skin cancers. More information is available at http://www.oncosec.com/.

This press release contains forward looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered such "forward looking statements." Forward looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause our results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include our ability to raise additional funding, our ability to acquire, develop or commercialize new products, uncertainties inherent in pre-clinical studies and clinical trials, unexpected new data, safety and technical issues, competition and market conditions. These and additional risks and uncertainties
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... -- RnRMarketResearch.com adds "CountryFocus: Healthcare, Regulatory and ... research report of 295 pages with latest updates, data ... The report " CountryFocus: Healthcare, Regulatory and Reimbursement ... and analysis of the healthcare, regulatory and reimbursement landscape ... key trends in the country,s healthcare market, and provides ...
(Date:3/30/2015)... RALEIGH, N.C. , March 30, 2015 /PRNewswire/ ... announced that the primary efficacy endpoint in the ... compared to placebo for the treatment of painful ... certain secondary endpoints showed statistically significant improvement over ... the product was observed.  The results of this ...
(Date:3/30/2015)... 30, 2015 China Nepstar Chain Drugstore ... a leading retail drugstore chain in China based ... announced its unaudited financial results for the fourth ... Financial HighlightsFor the quarter ended December 31, 2014: ... compared to the fourth quarter of 2013 ...
Breaking Medicine Technology:Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 2Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 3Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 4Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 5BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 2BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 3BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 4BioDelivery Sciences Announces Primary Endpoint in Phase 3 Study of Clonidine Topical Gel for Painful Diabetic Neuropathy Not Met, Though Encouraging Results Support Continued Development 5China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 11China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 12China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 13China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 14China Nepstar Chain Drugstore Ltd. Reports Fourth Quarter and Fiscal Year 2014 Financial Results 15
... Corporation (Nasdaq: LMNX ) today announced financial ... September 30, 2010.  Financial and operating highlights include the ... $33.9 million, a 16 percent increase over the third ... system bringing affordable multiplexing to laboratories worldwide Third ...
... Nov. 4, 2010 eResearchTechnology, Inc. (ERT), (Nasdaq: ... services to the pharmaceutical, biotechnology, and medical device industries, ... ended September 30, 2010.  Unless otherwise noted, all comparative ... year ago.  The financial results for the third quarter ...
Cached Medicine Technology:Luminex Corporation Reports Third Quarter 2010 Results 2Luminex Corporation Reports Third Quarter 2010 Results 3Luminex Corporation Reports Third Quarter 2010 Results 4Luminex Corporation Reports Third Quarter 2010 Results 5Luminex Corporation Reports Third Quarter 2010 Results 6Luminex Corporation Reports Third Quarter 2010 Results 7Luminex Corporation Reports Third Quarter 2010 Results 8Luminex Corporation Reports Third Quarter 2010 Results 9ERT Reports Third Quarter 2010 Results 2ERT Reports Third Quarter 2010 Results 3ERT Reports Third Quarter 2010 Results 4ERT Reports Third Quarter 2010 Results 5ERT Reports Third Quarter 2010 Results 6ERT Reports Third Quarter 2010 Results 7ERT Reports Third Quarter 2010 Results 8ERT Reports Third Quarter 2010 Results 9ERT Reports Third Quarter 2010 Results 10ERT Reports Third Quarter 2010 Results 11ERT Reports Third Quarter 2010 Results 12ERT Reports Third Quarter 2010 Results 13
(Date:3/30/2015)... California (PRWEB) March 30, 2015 ... as radioactive isotopes, radiopharmaceuticals are used as tracers ... global market for radiopharmaceuticals is driven by the ... in the field of cardiology, neurology, pulmonology, and ... by the well-established use of radioisotopes in diagnostic ...
(Date:3/30/2015)... Daily sun exposure, stressors and environmental factors ... folds and other giveaways of age. However, advances in ... to hit the pause button, delaying the impact of ... or hack to rejuvenate any facial feature. , ... (AAFPRS) explores the intricacies of The Aging Face ...
(Date:3/30/2015)... March 30, 2015 Mid-America ATTC ... library of medications used in behavioral health and ... iPad and Android—is a convenient, electronic version of ... 1999. The useful resource provides up-to-date information on ... and frequency, side effects, emergency conditions, cautions, considerations ...
(Date:3/30/2015)... 2015 BioFit Engineered ... manufacturer of ergonomic seating solutions, now offers ... new upholsteries bolster the company’s existing selection ... providing disinfectable, green choices. , The BioFit ... purveyor CF Stinson. Six disinfectable patterns consisting ...
(Date:3/29/2015)... 2015 At the 2015 International Health ... introduced the new Fonda wall mounted heater and ... Club owners and facilities managers with saunas smaller than ... design of the Fonda heater. With an attractive ... an immediate upgrade for a sauna, especially when mounted ...
Breaking Medicine News(10 mins):Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 2Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 3Health News:Expanding Commercial Use in Nuclear Imaging Drives Demand for Radiopharmaceuticals, According to a New Report by Global Industry Analysts, Inc. 4Health News:New AAFPRS Infographic Addresses Concerns and Provides Aging Face Solutions 2Health News:Popular Publication on Behavioral Health Medications Now An App 2Health News:BioFit Adds Bleachable Upholstery Options to Seating Line 2Health News:Helo Commercial Introduces Fonda Sauna Heater and Sauna and Steam Continuing Education Program at IHRSA 2
... new and novel computer modeling platform developed through intensive, ... and cities to be more prepared for catastrophic public ... American Medical Association,s Disaster Medicine and Public Health ... to Multihazard Modeling and Simulation," is based on the ...
... Telemedicine, Mammography and Health Screenings on Wheels Expand Access ... June 11 Kaiser Permanente, one of America,s leading ... a new generation of mobile health. A first-of-its-kind, 500-sq-foot, ... home island of Hawaii, known to many as the ...
... off brain cell damage, lab study finds , THURSDAY, June ... may start with one protein that somehow goes astray and ... say. , Mad cow disease is considered a prion disease ... prion protein, or PrP, which normally is found on the ...
... is pleased to offer its stock alerts service to ... move and in the news can receive FREE Alerts by visiting ... , Today,s focused alerts include: Hemispherx Biopharma, Inc. (Amex: ... Cell Therapeutics, Inc. (Nasdaq: CTIC ), Cancer Therapeutics Inc. ...
... June 11 National figures, stars from the world of sports ... gathered today in Anaheim, California to celebrate 20 years of Drug ... reach of every American in need at the National Association of ... , Speaking in front of a crowd representing every U.S. state ...
... most common cancers in China. Although the association between ... studied, the relation between smoking, alcohol drinking, family history ... cancer still remains uncertain. So it is important to ... of sporadic colorectal cancer. A research team led ...
Cached Medicine News:Health News:A new computer modeling program can help hospitals prepare for the worst 2Health News:Kaiser Permanente Unveils the Nation's Most Wired Mobile Health Vehicle 2Health News:Kaiser Permanente Unveils the Nation's Most Wired Mobile Health Vehicle 3Health News:Protein Branded As Culprit in Mad Cow Disease 2Health News:GlobalEquityReport.com Issues Cancer Stocks On The Move Today: HEB, GNBT, CTIC, CTHP, DNDN 2Health News:U.S. Drug Czar Addresses 2,500 Drug Court Professionals, Voices Strong Support for Expanding Drug Courts Throughout the Nation 2Health News:U.S. Drug Czar Addresses 2,500 Drug Court Professionals, Voices Strong Support for Expanding Drug Courts Throughout the Nation 3
... Superior optics and workmanship are the hallmark ... temperature sensitivity in mind. The top (incident) ... illumination, eliminating shadows while remaining cool to ... are available with 10x to 44x zoom ...
... system expandability: the first inverted microscope to ... infinity space. Multi-port design enables optical input/output ... variety of illumination and detector equipment. Extendable ... an optional light source and other attachments ...
... The OLY-150 is an monochrome IR/DIC video camera. ... give you all the image quality and flexibility ... video cameras provide a high-resolution, real-time image of ... a video monitor or TV. You can even ...
... automatic fluorescence photomicrography system that greatly simply ... most difficult specimens. Designed with real life ... solution to the complex problem of fluorescence ... control, the system utilizes special programs designed ...
Medicine Products: